Does CXCL10 inhibition compromise CNS immune surveillance during chronic treatment?

PARTIALLY ADDRESSED

The debate highlighted major safety concerns about blocking CXCL10, particularly increased infection susceptibility, but no long-term studies exist. This critical safety gap must be resolved before therapeutic development can proceed. Source: Debate session sess_SDA-2026-04-03-gap-aging-mouse-brain-20260402 (Analysis: SDA-2026-04-03-gap-aging-mouse-brain-20260402)

Priority: 0.90 Domain: neuroimmunology Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Does CXCL10 inhibition compromise CNS immune surveillance during chronic treatment? is a 0.9 priority gap in neuroimmunology. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Does CXCL10 inhibition compromise CNS immune surveillance during chronic treatment? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (7)

CXCL10InflammationCXCL10CD8+ T cell recruitmentCXCL10AgingCXCL10microgliaGENESCXCL10
▸ Show 2 more

alters (2)

SNCACXCL10AΒ1-42CXCL10

associated with (8)

CXCL10MS lesionsA1 Reactive AstrocytesCXCL10CXCL10JAK1/2/STAT1 SignalingA1 AstrocytesCXCL10CXCL10Neuroinflammation
▸ Show 3 more

biomarker for (3)

CXCL10FrailtyCXCL10DermatomyositisCXCL10Juvenile Dermatomyositis

causes (1)

CXCL10Als

causes (CXCL10 acts as chemokine to recruit cytotoxic CD8+) (1)

CXCL10CD8+ T cell recruitment

contributes to (1)

CXCL10Psoriatic Arthritis

correlates with (1)

CXCL10T Cell Infiltration

describes (1)

cell-types-nodes-ranvier-neurodCNS

downregulates (1)

KCNK2CXCL10

encodes (1)

CXCL10CXCL10

expressed in (1)

BDNFCNS

infects (1)

JEVCNS

inhibits (2)

SPRY1CXCL10FIP200CXCL10

involved in (2)

CXCL10Interferon-Stimulated ResponseCXCL10Th1-Type Response

is expressed outside (1)

38898538CNS

is the primary lipid carrier within (1)

29563219CNS

mediates (3)

CXCL10Keratinocyte SPRY1/CXCL10/Periarticular CD14hi Macrophage/TNF-α AxisBI-hTFR1CNSCXCL10Immune Cell Recruitment

participates in (1)

CXCL10oxidative stress response

penetrate (1)

39009412CNS

regulates (2)

CXCL10T-cell traffickingCXCL10CD8+ T-cell recruitment

targets (3)

h-245c3e93CXCL10h-c5698ce3CXCL10h-724e3929CXCL10

upregulates (5)

CXCL10DermatomyositisA1 Reactive AstrocytesCXCL10Reactive AstrocytesCXCL10IFNGCXCL10MicrogliaCXCL10
🕑 Activity Feed
update on knowledge_gap by max_gmail 2026-04-26T18:31
update on knowledge_gap by None 2026-04-25T22:15
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps